Cargando…

Tolcapone-Enhanced Neurocognition in Healthy Adults: Neural Basis and Predictors

BACKGROUND: Failure of procognitive drug trials in schizophrenia may reflect the clinical heterogeneity of schizophrenia, underscoring the need to identify biomarkers of treatment sensitivity. We used an experimental medicine design to test the procognitive effects of a putative procognitive agent,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhakta, Savita G, Light, Gregory A, Talledo, Jo A, Balvaneda, Bryan, Hughes, Erica, Alvarez, Alexis, Rana, Brinda K, Young, Jared W, Swerdlow, Neal R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Regular Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716101/ https://www.ncbi.nlm.nih.gov/pubmed/29020372 http://dx.doi.org/10.1093/ijnp/pyx074

Ejemplares similares

Auditory discrimination and frequency modulation learning in schizophrenia patients: amphetamine within-subject dose response and time course
por: Swerdlow, Neal R., et al.
Publicado: (2023)

Right inferior frontal cortex activity correlates with tolcapone responsivity in problem and pathological gamblers
por: Kayser, Andrew S., et al.
Publicado: (2016)

Utility of tolcapone in fluctuating Parkinson’s disease
por: Stocchi, Fabrizio, et al.
Publicado: (2006)

Effects of tolcapone and bromocriptine on cognitive stability and flexibility
por: Cameron, Ian G. M., et al.
Publicado: (2018)

Formulation of Sustained Release Hydrophilic Matrix Tablets of Tolcapone with the Application of Sedem Diagram: Influence of Tolcapone’s Particle Size on Sustained Release
por: Nardi-Ricart, Anna, et al.
Publicado: (2020)

The efficacy of homemade tolcapone in the treatment of patients with Parkinsons disease
por: Zhang, Pei-Lan, et al.
Publicado: (2018)

Safety and efficacy of tolcapone in Parkinson’s disease: systematic review
por: Artusi, Carlo Alberto, et al.
Publicado: (2021)

Micro- and Nano-Systems Developed for Tolcapone in Parkinson’s Disease
por: Casanova, Yaquelyn, et al.
Publicado: (2022)

Tolcapone: review of its pharmacology and use as adjunctive therapy in patients with Parkinson’s disease
por: Truong, Daniel D
Publicado: (2009)

Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity
por: Sant'Anna, Ricardo, et al.
Publicado: (2016)

Tolcapone induces oxidative stress leading to apoptosis and inhibition of tumor growth in Neuroblastoma
por: Maser, Tyler, et al.
Publicado: (2017)

Addition of Tolcapone in Intrajejunal Levodopa Infusion Therapy Requires a Pronounced Dose Reduction
por: Schröter, Nils, et al.
Publicado: (2020)

Tolcapone Potently Inhibits Seminal Amyloid Fibrils Formation and Blocks Entry of Ebola Pseudoviruses
por: Qiu, Mengjie, et al.
Publicado: (2020)

Characterization of Neurophysiologic and Neurocognitive Biomarkers for Use in Genomic and Clinical Outcome Studies of Schizophrenia
por: Light, Gregory A., et al.
Publicado: (2012)

Electrophysiological biomarkers of behavioral dimensions from cross-species paradigms
por: Cavanagh, James F., et al.
Publicado: (2021)

Correction to: Electrophysiological biomarkers of behavioral dimensions from cross-species paradigms
por: Cavanagh, James F., et al.
Publicado: (2022)

Catechol-o-methyltransferase inhibitor tolcapone improves learning and memory in naïve but not in haloperidol challenged rats
por: Mihaylova, Anita, et al.
Publicado: (2019)

Tolcapone in Obsessive Compulsive disorder: A Randomized Double-Blind Placebo-Controlled Crossover Trial
por: Grant, Jon E., et al.
Publicado: (2021)

Author Correction: Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity
por: Sant’Anna, Ricardo, et al.
Publicado: (2023)

Neurocognitive normality in schizophrenia revisited
por: Heinrichs, R. Walter, et al.
Publicado: (2015)

COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson’s disease (PD): relevance for motor and non-motor features
por: Antonini, Angelo, et al.
Publicado: (2008)

Elucidating Differences in the Hepatotoxic Potential of Tolcapone and Entacapone With DILIsym(®), a Mechanistic Model of Drug‐Induced Liver Injury
por: Longo, DM, et al.
Publicado: (2016)

Tolcapone improves outcomes in patients with Parkinson disease treated by levodopa/carbidopa intestinal gel: A pilot study
por: Valkovič, Peter, et al.
Publicado: (2022)

Theta oscillations in prolactinomas: Neurocognitive deficits in executive controls
por: Cao, Chenglong, et al.
Publicado: (2020)

Effects of pharmacological and genetic regulation of COMT activity in alcohol use disorder: a randomized, placebo-controlled trial of tolcapone
por: Schacht, Joseph P., et al.
Publicado: (2022)

Differential Interactome Based Drug Repositioning Unraveled Abacavir, Exemestane, Nortriptyline Hydrochloride, and Tolcapone as Potential Therapeutics for Colorectal Cancers
por: Beklen, Hande, et al.
Publicado: (2021)

Exploring the neurocognitive basis of episodic recollection in autism
por: Cooper, Rose A., et al.
Publicado: (2018)

Altered structural brain changes and neurocognitive performance in pediatric HIV
por: Yadav, Santosh K., et al.
Publicado: (2017)

Network structure-function coupling and neurocognition in cerebral small vessel disease
por: Tay, Jonathan, et al.
Publicado: (2023)

Altered intrinsic functional coupling between core neurocognitive networks in Parkinson's disease
por: Putcha, Deepti, et al.
Publicado: (2015)

Pramipexole effects on startle gating in rats and normal men
por: Swerdlow, Neal R., et al.
Publicado: (2009)

Predictors of Neurocognitive Syndromes in Combat Veterans
por: Roy, Michael J, et al.
Publicado: (2015)

Principal Components of Heritability From Neurocognitive Domains Differ Between Families With Schizophrenia and Control Subjects
por: Wiener, Howard, et al.
Publicado: (2013)

Distinct neural correlates of trait resilience within core neurocognitive networks in at-risk children and adolescents
por: Iadipaolo, Allesandra S., et al.
Publicado: (2018)

The Neurocognitive Basis for Impaired Dual-Task Performance in Senior Fallers
por: Nagamatsu, Lindsay S., et al.
Publicado: (2016)

Morality is in the eye of the beholder: the neurocognitive basis of the “anomalous‐is‐bad” stereotype
por: Workman, Clifford I., et al.
Publicado: (2021)

Neurocognitive basis of deductive reasoning in children varies with parental education
por: Demir‐Lira, Ö. Ece, et al.
Publicado: (2021)

Multiprofessional follow‐up programmes are needed to address psychosocial, neurocognitive and educational issues in children with brain tumours
por: van't Hooft, I, et al.
Publicado: (2015)

Alteration of brain network topology in HIV-associated neurocognitive disorder: A novel functional connectivity perspective
por: Abidin, Anas Z., et al.
Publicado: (2017)

Emotion regulation in adults with Klinefelter syndrome (47,XXY): Neurocognitive underpinnings and associations with mental health problems
por: van Rijn, Sophie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gkbk7dmrudfv3dpi5o4qrr7omi